Skip to content

Honey and cesarean wound

Effect of honey on wound healing and scar of cesarean

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT138802051845N1
Enrollment
120
Registered
2010-05-29
Start date
2008-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wound and cesarean scar. Complications predominantly related to the puerperium

Interventions

Intervention 1: honey, local use, twice a day for 16 consecutive days. Intervention 2: Placebo, local use, twice a day for 16 consecutive days.
Treatment - Drugs
Placebo
honey, local use, twice a day for 16 consecutive days
Placebo, local use, twice a day for 16 consecutive days

Sponsors

Arak University of Medical Science
Lead Sponsor
Barij essence Company
Collaborator

Eligibility

Sex/Gender
Female
Age
17 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 35-17, level of education the mother not less than five grade, gestational age between 37 to 42 weeks based on the first day since the last menstrual period (LMP) or ultrasound, cesarean delivery, uterine incision and lower transverse incision Faneshtyl skin, maximum two previous deliveries Exclusion criteria: previous cesarean section, previous surgery in the lower abdominal area (site of cesarean section), smoking (cigarettes, hookah), known history of medical conditions known to have interaction to wound healing (Systemic or chronic diseases, heart, kidney, liver, respiratory, coagulation, connective tissue, skin, thyroid, diabetes, anemia, cancer, infectious diseases, or psychological), consumption of medications known to have interaction to healing and scar formation (glucocorticoids, anticoagulations, immunosuppressives, broad spectrum antibiotics, antihistamins, calcium antagonists, chemotherapy and radiotherapy), obstetric problems (such as eclampsia, preeclampsia, placenta previa, placental abruptia, multiple gestation, chorioamniotitis, being impregnated with a liquid Meconium and poly Hydramnyvs), mental complications such as death of parents, spouse, child, separation from a spouse, serious differences with her husband, Major changes in life situation, severe financial problems during the past month

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Healing of cesarean wound. Timepoint: 10th days after cesaren operation. Method of measurement: reeda scale.

Secondary

MeasureTime frame
Cesarean scar. Timepoint: 40th days after cesarean operation. Method of measurement: vancouver scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTooba Heidari

Arak University of Medical Science

t_heidari@arakmu.ac.ir , heidari.m.831@gmail.com+98 86141735035

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026